Brainlabs IPO Programmatically
The medical technology and software company Brainlab has officially announced its plan to conduct an initial public offering (IPO) on the Prime Standard of the Frankfurt Stock Exchange in the coming weeks. This move is expected to be one of the largest German stock market events of the year.
Background and Company Profile
- Foundation and Development: Stefan Vilsmeier founded Brainlab in 1989. The headquarters is located in Munich, and around 2,000 employees are employed. The company specializes in medical software for surgical procedures as well as tumor radiation therapy and is represented in about 4,000 healthcare facilities worldwide.
- Corporate Management: Vilsmeier is stepping back from day-to-day operations but remains as a long-term investor.
Details on the Planned IPO
- The IPO will take place on the Prime Standard in the coming weeks. Through a capital increase, new shares are to be issued, with a target revenue of around €600 million and a company valuation of about €3 billion.
- The proceeds will be used for the expansion of the business model and to strengthen the balance sheet.